Díaz EMA, López CNR, Juárez AFG, Díaz EJI

Language: Spanish
References: 14
Page: 31-38
PDF size: 625.30 Kb.

ABSTRACT

Hemangiopericytoma is a rare tumor of the central nervous system with varying degrees of malignancy and poor prognosis. According to the WHO classification, these lesions can be classified as grade I (benign), grade II (slow-growing tumors, some with a tendency to progress to more malignancy) and grade III or anaplastic (infiltrating tumors with anaplastic cells and a greater number of mitosis), the latter with a higher recurrence rate and metastatic capacity.
Histologically they are characterized by having a compact spindle cell component and a branched stromal vascular pattern in the shape of a “deer horn”.
The clinical picture varies according to its location and size, the most frequent signs and symptoms are seizures, headache and focal neurological deficit.
The initial diagnostic approach is computed tomography that provides suspicious data, however, magnetic resonance imaging is the main diagnosis, since it provides important data that becomes more important with the use of functional sequences such as tractography.
We present the report of a clinical case with literature review and the most significant findings in imaging studies.

REFERENCES

1. Gengler C, Guillou L. Gengler C, Guillou L. Solitary fibrous tumour and haemangiopericytoma: evolution of a concept. Histopathology. 2006;48(1):63-74.

2. Márquez J, Rodríguez F, Torres A, Fernández A. Hemangiopericytoima meníngeo anaplasico: presentación de un caso. Rev colomb. Radio. 2012;23(2):3510-3.

3. Anderson MD, Colen RR, Tremont-Lukats IW. Imaging mimics of primary malignant tumors of the central nervous system (CNS). Curr Oncol Rep. 2014;16:399.

4. De Robles P, Fiest KM, Frolkis AD, Pringsheim T, Atta C, St Germaine-Smith C, et al. The worldwide incidence and prevalence of primary brain tumors: a systematic review and meta-analysis. Neuro Oncol. 2015 Jun;17(6):776-83.

5. Perez L, Perez E, Hernandez V, Alcocer P. Hemangiopericitoma/ tumor fibroso solitario: presentación de caso y revisión de literatura. Archivos de neurociencias. 2019.

6. Champeaux C, Khan A, Wilson E, Thorne L, Dunn L. Meningeal hemangiopericytoma and solitary fibrous tumor: A retrospective bi centre study for outcome and prognostic factor asseement. J neurooncol. 2017;134(2):387-95.

7. Smith A, Horkanyne S, Schroeder J et-al. From the radiologic pathology archives: mass lesions of the dura: beyond meningioma-radiologic-pathologic correlation. Radiographics. 2014;34(2):295-312.

8. Fountas KN, Kapsalaki E, Kassam M, et al. Managemnet of intracranial meningeal hemangiopericytomas: outcome and experience. Neurosurg rev. 2006;29(2):145-53.

9. Zhou Jl, Liu Jl, Zhang J, Zhang M. Thirty-nine cases of intracranial hemangiopericytoma and anaplastic hemangiopericytoma: a retrospective review of MRI features and pathological findings. Eur J radiol. 2012;81(11):3504-10.

10. Liu G, Chen Zy, Ma L, Lou X, Li Sj, Wang Yl. Intracranial hemangiopericytoma: MR imaging findings and diagnostic usefulness of minimun ADC, value. J Magn Reson Imaging. 2013;38(5):1146-51.

11. Burtscher IM, Skagerberg G, Geijer B, Englund E, Ståhlberg F, Holtås S. Proton MR spectroscopy and preoperative diagnostic accuracy: an evaluation of intracranial mass lesions characterized by stereotactic biopsy findings. AJNR Am J Neuroradiol. 2000;21:84-93.

12. Ma J, Su S, Yue S, Zhao Y, Li Y, Chen X, Ma H, et al. Preoperative Visualization of Cranial Nerves in Skull Base Tumor Surgery Using Diffusion Tensor Imaging Technology. Turk Neurosurg. 2016;26(6):805-12.

13. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Ellison DW, Figarrella BD, Perry A, Reifenberger G, Deimling A. WHO Classification of Tumours of the Central Nervous System. 4th Revised. World Health Organization; 2016.

14. Sung KS, Moon JH, Kim EH, Kang SG, Kim SH, Suh CO, Kim SH, Lee KS, Chang WS, Chang JH. Solitary fibrous tumor/ Hemangiopericytoma: treatment results based on 2016 WHO classification. J Neurosurg. 2017;130(2).